Amgen
Jean Pierre Llanos Ackert, MD, ATSF, serves as the Executive Medical Director and Global Medical Affairs Lead for Tezepelumab and the pulmonary pipeline at Amgen since April 2019. Prior to this, Jean Pierre held multiple senior leadership roles at GSK, including Senior Director for Medical Affairs of Nucala, and at Abbott, where responsibilities included directing medical affairs for Latin America and Canada. Jean Pierre's earlier experience includes roles as a Pediatric Pulmonologist and Pediatrician in various institutions, contributing to clinical development and medical affairs. Educated in General Medicine and Pediatrics, Jean Pierre holds specialized fellowships in Pediatric Pulmonology from Ludwig-Maximilians-Universität München and advanced degrees from Universidad Peruana Cayetano Heredia. Additionally, Jean Pierre served as the European Respiratory Society National Delegate for Peru from 2006 to 2008.
This person is not in any teams
Amgen
275 followers
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.